Baxter International (BAX) Cash from Investing Activities (2009 - 2026)
Baxter International (BAX) posted quarterly Cash from Investing Activities of -$117.0 million for Q2 2026, down 1.74% year-over-year from -$119.1 million in Q2 2025, and up 12.03% quarter-over-quarter from -$133.0 million in Q1 2026.
Baxter International (BAX) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Baxter International (BAX) has reported Cash from Investing Activities for 18 consecutive years, with -$117.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash from Investing Activities fell 1.74% year-over-year to -$117.0 million; the TTM figure through Jun 2026 stood at -$559.0 million (down 120.1% YoY), while the FY2025 annual figure was $2.8 billion, up 553.83% from the prior year.
- Cash from Investing Activities improved to -$117.0 million in Q2 2026 per BAX's latest filing, from -$133.0 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $3.8 billion in Q3 2023 and bottomed at -$304.0 million in Q1 2022.
- Historically, Cash from Investing Activities has averaged $235.9 million across 5 years, with a median of -$168.0 million in 2023.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 2157.61% — and 2024, when it plunged 104.33%.
- Baxter International's Cash from Investing Activities stood at -$256.0 million in 2022, then climbed by 10.16% to -$230.0 million in 2023, then gained by 10.87% to -$205.0 million in 2024, then grew by 3.41% to -$198.0 million in 2025, then soared by 40.91% to -$117.0 million in 2026.
- Business Quant data shows BAX's Cash from Investing Activities at -$117.0 million in Q2 2026, -$133.0 million in Q1 2026, and -$198.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -241.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -383.65 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -461.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -87.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -117.00 Mn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | -82.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -117.00 Mn |
| Jun 30, 2026 | -117.00 Mn |
| Mar 31, 2026 | -133.00 Mn |
| Mar 31, 2026 | -133.00 Mn |
| Dec 31, 2025 | -3.50 Bn |
| Dec 31, 2025 | -3.50 Bn |
| Sep 30, 2025 | 3.28 Bn |
| Sep 30, 2025 | 3.28 Bn |
| Jun 30, 2025 | -3.50 Bn |
| Jun 30, 2025 | -3.50 Bn |
| Mar 31, 2025 | 3.27 Bn |
| Mar 31, 2025 | 3.27 Bn |
| Dec 31, 2024 | -205.00 Mn |
| Dec 31, 2024 | -205.00 Mn |
| Sep 30, 2024 | -164.00 Mn |
| Sep 30, 2024 | -164.00 Mn |
| Jun 30, 2024 | -157.00 Mn |
| Jun 30, 2024 | -157.00 Mn |
| Mar 31, 2024 | -100.00 Mn |
| Mar 31, 2024 | -100.00 Mn |